rs17880847

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000546.6(TP53):​c.1100+30A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0118 in 1,511,366 control chromosomes in the GnomAD database, including 118 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0090 ( 7 hom., cov: 32)
Exomes 𝑓: 0.012 ( 111 hom. )

Consequence

TP53
NM_000546.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.934

Publications

16 publications found
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
TP53 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Li-Fraumeni syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
  • Li-Fraumeni syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • adrenocortical carcinoma, hereditary
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • bone marrow failure syndrome 5
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • colorectal cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • choroid plexus carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-7670579-T-A is Benign according to our data. Variant chr17-7670579-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 810938.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00899 (1363/151652) while in subpopulation NFE AF = 0.0147 (1000/67910). AF 95% confidence interval is 0.014. There are 7 homozygotes in GnomAd4. There are 623 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1363 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000546.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
NM_000546.6
MANE Select
c.1100+30A>T
intron
N/ANP_000537.3
TP53
NM_001126112.3
c.1100+30A>T
intron
N/ANP_001119584.1
TP53
NM_001407262.1
c.1100+30A>T
intron
N/ANP_001394191.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
ENST00000269305.9
TSL:1 MANE Select
c.1100+30A>T
intron
N/AENSP00000269305.4
TP53
ENST00000445888.6
TSL:1
c.1100+30A>T
intron
N/AENSP00000391478.2
TP53
ENST00000610292.4
TSL:1
c.983+30A>T
intron
N/AENSP00000478219.1

Frequencies

GnomAD3 genomes
AF:
0.00898
AC:
1361
AN:
151532
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00216
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00973
Gnomad ASJ
AF:
0.0150
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00208
Gnomad FIN
AF:
0.00285
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0147
Gnomad OTH
AF:
0.0144
GnomAD2 exomes
AF:
0.00945
AC:
2222
AN:
235112
AF XY:
0.00943
show subpopulations
Gnomad AFR exome
AF:
0.00171
Gnomad AMR exome
AF:
0.0109
Gnomad ASJ exome
AF:
0.0172
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00401
Gnomad NFE exome
AF:
0.0136
Gnomad OTH exome
AF:
0.0163
GnomAD4 exome
AF:
0.0121
AC:
16492
AN:
1359714
Hom.:
111
Cov.:
20
AF XY:
0.0120
AC XY:
8166
AN XY:
679756
show subpopulations
African (AFR)
AF:
0.00133
AC:
42
AN:
31492
American (AMR)
AF:
0.0110
AC:
472
AN:
42794
Ashkenazi Jewish (ASJ)
AF:
0.0149
AC:
375
AN:
25192
East Asian (EAS)
AF:
0.0000767
AC:
3
AN:
39088
South Asian (SAS)
AF:
0.00223
AC:
185
AN:
82982
European-Finnish (FIN)
AF:
0.00438
AC:
231
AN:
52684
Middle Eastern (MID)
AF:
0.00777
AC:
42
AN:
5406
European-Non Finnish (NFE)
AF:
0.0142
AC:
14524
AN:
1023066
Other (OTH)
AF:
0.0108
AC:
618
AN:
57010
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
765
1530
2294
3059
3824
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
512
1024
1536
2048
2560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00899
AC:
1363
AN:
151652
Hom.:
7
Cov.:
32
AF XY:
0.00841
AC XY:
623
AN XY:
74116
show subpopulations
African (AFR)
AF:
0.00216
AC:
89
AN:
41288
American (AMR)
AF:
0.00979
AC:
149
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.0150
AC:
52
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5126
South Asian (SAS)
AF:
0.00250
AC:
12
AN:
4800
European-Finnish (FIN)
AF:
0.00285
AC:
30
AN:
10522
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0147
AC:
1000
AN:
67910
Other (OTH)
AF:
0.0142
AC:
30
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
70
139
209
278
348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00865
Hom.:
0
Bravo
AF:
0.00972
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not provided (2)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Li-Fraumeni syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.11
DANN
Benign
0.79
PhyloP100
-0.93
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17880847; hg19: chr17-7573897; COSMIC: COSV53152345; API